Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 8, Issue 3, 2003, Pages 227-235

  Lee, Paul ^b   Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NONE

Author keywords

Antioxidant reserve; Atherosclerosis; Chemiluminescent activity of white blood cells; Flaxseed oil; Hypercholesterolemia; Malondialdehyde; Oxidative stress

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINSEED OIL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; HYPERCHOLESTEROLEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

EID: 0141455327     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840300800308     Document Type: Article

References (45)

1. Hettiarachchy NS, Hareland GA, Ostenson A, et al. Chemical composition of 11 flaxseed varieties grown in North Dakota. Proc Flax Inst 53:36-40, 1990
2. Oomah BD, Mazza G. Flaxseed proteins: A review. Food Chem 48:109-114, 1993
3. Kelley DS, Branch LB, Love JE, et al. Dietary alpha-linolenic acid and immunocompetence in humans. Am J Clin Nutr 53:40-46, 1991
4. Hunter JE. N-3 fatty acids from vegetable oils. Am J Clin Nutr 51:809-814, 1990
5. Prasad K, Mantha SV, Muir AD, et al. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136:367-375, 1998
6. Obermeyer WR, Musser SM, Betz JW, et al. Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 208:6-12, 1995
7. Westcott ND, Muir AD. Process for extracting lignans from flaxseed. US Patent No. 5705618, Jan. 1998
8. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Circulation 99:1355-1362, 1999
9. Cox CP, Wood KL. Selective antagonism of platelet activating factor (PAF)-induced aggregation and secretion of washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. Thromb Res Suppl 47:249-257, 1987
10. Prasad K. Hydroxyl radical scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem 168:116-117, 1997
11. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Intl J Angiol 9:220-225, 2000
12. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989
13. Chandrasekar B, Fernandes G. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893-898, 1994
14. Fisher M, Levine PH, Weiner BH, et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 51:804-808, 1990
15. Fisher M, Upchurch KS, Levine PH, et al. Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 10:387-392, 1986
16. Prasad K. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132:69-75, 1997
17. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125:958-973, 1993
18. Prasad K, Kalra J, Lee P. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of probucol. Int J Angiol 3:100-112, 1994
19. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation 85:2337-2344, 1992
20. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84:5928-5931, 1987
21. Sanders TA, Roshanai F. The influence of different types of omega-3 poly-unsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci 64:91-99, 1983
22. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463, 1991
23. Leaf A, Weber P. Cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549-557, 1988
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
25. Prasad K, Gupta JB, Kalra J, et al. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28:375-385, 1996
26. Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the development of type-2 diabetes in Zucker rat. J Lab Clin Med 138:32-39, 2001
27. Ranhotra GS, Gelroth JA, Glaser BK, et al. Lipidemic responses in rats fed flaxseed oil and meal. Cereal Chem 70:364-366, 1993
28. Ingram AJ, Parbtani A, Clark WF, et al. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am J Kidney Dis 25:320-329, 1995
29. Kestin M, Clifton P, Belling GB, et al. N-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am J Clin Nutr 51:1028-1034, 1990
30. Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids, lipoproteins, and apo-proteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312:1210-1216, 1985
31. Sanders TA, Sullivan DR, Reeve J, et al. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 5:459-465, 1985
32. Harris WS, Windsor SL, Caspermeyer JJ, Modification of lipid related atherosclerosis risk factors by omega-3 fatty acid ethyl esters in hypertriglyceridemic patients. J Nutr Biochem 4:706-712, 1993
33. Davis HR, Bridenstine RT, Vesselinovitch D, et al. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Arteriosclerosis 7:441-449, 1987
34. Nestel PJ, Connor WE, Reardon MF, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74:82-89, 1984
35. Stansby ME. Nutritional properties of fish oil. World Rev Nutr Dietetics 11:46-105, 1969
36. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217-1227, 1985
37. Prasad K, Mantha SV, Kalra J, et al. Purpurogallin in the prevention of hypercholesterolemic atherosclerosis. Intl J Angiol 6:157-166, 1997
38. Prasad K, Mantha SV, Kalra J, et al. Prevention of hypercholesterolemic atherosclerosis by garlic, an antioxidant. J Cardiovasc Pharmacol Therapeut 2:309-320, 1997
39. Mantha SV, Prasad M, Kalra J, et al. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis 101:135-144, 1993
40. Kapoor R, Prasad K. Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Radic Biol Med 21:609-618, 1996
41. Egan RW, Paxton J, Kuehl FA Jr. Mechanisms for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 251:7329-7335, 1976
42. Panganamala RV, Sharma HM, Heikkila JC, et al. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohol and methional in the inhibition of prostaglandin synthesis. Prostaglandins 11:599-607, 1976
43. Murota S, Morita I, Suda N. The control of vascular endothelial injury. Ann NY Acad Sci 598:182-187, 1990
44. Sacks T, Moldow CF, Craddock PR, et al. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocyte. An in vitro model of immune vascular damage. J Clin Invest 61:1161-1167, 1978
45. Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488-500, 1986